Hepatitis B Vaccine (Recombinant) Completed Phase 3 Trials for End Stage Renal Disease (ESRD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01195246Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis